ABBV-257
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-257, covering 2016-03-03 to 2016-03-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis [Phase 1]